6–0 fine middle cerebral artery occlusion (mcao) suture (Doccol Corporation)
Structured Review

6–0 Fine Middle Cerebral Artery Occlusion (Mcao) Suture, supplied by Doccol Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/6–0 fine middle cerebral artery occlusion (mcao) suture/product/Doccol Corporation
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "CLEC14A deficiency exacerbates neuronal loss by increasing blood-brain barrier permeability and inflammation"
Article Title: CLEC14A deficiency exacerbates neuronal loss by increasing blood-brain barrier permeability and inflammation
Journal: Journal of Neuroinflammation
doi: 10.1186/s12974-020-1727-6
Figure Legend Snippet: Loss of CLEC14A exacerbated cerebral injury with VEGFR2 activation in MCAO stroke model. a , c Images of whole brains and comparison of Evans blue dye (EB) leakage in brains (P8 and adult) after EB injection (intraperitoneal route) in WT and CLEC14A KO mice ( n = 6, each group). b , d The quantitative analysis of Evans blue (EB) dye extravasation using spectrophotometer, 24 h after intraperitoneal injection of EB dye. e TTC staining of brain slices in the sham, WT, and CLEC14A KO groups 24-h post ischemia-reperfusion. Severe infarction was present in the CLEC14A KO group. Scale bar = 1 mm. f Percentage of infarct volume in the WT and CLEC14A KO groups 24 h after ischemia-reperfusion. g Neurological scores of WT and CLEC14A KO mice were evaluated. h VEGFR2, pVEGFR2 protein expression in ipsilateral brain lysate after ischemia-reperfusion injury. i , j Quantification data of relative pVEGFR2 and VEGFR2 protein expression. n = 6 per group; * P < 0.05, ** P < 0.01, *** P < 0.001. The results are mean values and the error bars represent the mean ± SD
Techniques Used: Activation Assay, Comparison, Injection, Spectrophotometry, Staining, Expressing